213 related articles for article (PubMed ID: 17005762)
1. Liver fibrosis in women with chronic hepatitis C: evidence for the negative role of the menopause and steatosis and the potential benefit of hormone replacement therapy.
Codes L; Asselah T; Cazals-Hatem D; Tubach F; Vidaud D; Paraná R; Bedossa P; Valla D; Marcellin P
Gut; 2007 Mar; 56(3):390-5. PubMed ID: 17005762
[TBL] [Abstract][Full Text] [Related]
2. Influence of steatosis on progression of fibrosis and virological response in chronic hepatitis C cases.
Rafi H; Kabbaj N; Salihoun M; Amrani L; Acharki M; Guedira M; Nya M; Amrani N
Arab J Gastroenterol; 2011 Sep; 12(3):136-8. PubMed ID: 22055591
[TBL] [Abstract][Full Text] [Related]
3. Effect of the interaction between steatosis and alcohol intake on liver fibrosis progression in chronic hepatitis C.
Serfaty L; Poujol-Robert A; Carbonell N; Chazouillères O; Poupon RE; Poupon R
Am J Gastroenterol; 2002 Jul; 97(7):1807-12. PubMed ID: 12135040
[TBL] [Abstract][Full Text] [Related]
4. Predictive factors for the severity of liver fibrosis in patients with chronic hepatitis C and moderate alcohol consumption.
Vădan R; Gheorghe L; Becheanu G; Iacob R; Iacob S; Gheorghe C
Rom J Gastroenterol; 2003 Sep; 12(3):183-7. PubMed ID: 14502317
[TBL] [Abstract][Full Text] [Related]
5. Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.
Di Martino V; Lebray P; Myers RP; Pannier E; Paradis V; Charlotte F; Moussalli J; Thabut D; Buffet C; Poynard T
Hepatology; 2004 Dec; 40(6):1426-33. PubMed ID: 15565616
[TBL] [Abstract][Full Text] [Related]
6. [Steatosis in chronic viral hepatitis C: frequency, risk factors and relationship with fibrosis].
Karoui S; Taieb Jomni M; Bellil K; Haouet S; Boubaker J; Filali A
Tunis Med; 2008 Jul; 86(7):670-5. PubMed ID: 19472729
[TBL] [Abstract][Full Text] [Related]
7. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
[TBL] [Abstract][Full Text] [Related]
8. Cryoglobulinemia is associated with steatosis and fibrosis in chronic hepatitis C.
Saadoun D; Asselah T; Resche-Rigon M; Charlotte F; Bedossa P; Valla D; Piette JC; Marcellin P; Cacoub P
Hepatology; 2006 Jun; 43(6):1337-45. PubMed ID: 16729318
[TBL] [Abstract][Full Text] [Related]
9. Impact of steatosis on progression of fibrosis in patients with mild hepatitis C.
Fartoux L; Chazouillères O; Wendum D; Poupon R; Serfaty L
Hepatology; 2005 Jan; 41(1):82-7. PubMed ID: 15690484
[TBL] [Abstract][Full Text] [Related]
10. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
Adinolfi LE; Ingrosso D; Cesaro G; Cimmino A; D'Antò M; Capasso R; Zappia V; Ruggiero G
Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
[TBL] [Abstract][Full Text] [Related]
11. The impact of hepatic steatosis on the natural history of chronic hepatitis C infection.
Cross TJ; Quaglia A; Hughes S; Joshi D; Harrison PM
J Viral Hepat; 2009 Jul; 16(7):492-9. PubMed ID: 19200134
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
[TBL] [Abstract][Full Text] [Related]
13. Fibrosis in chronic hepatitis C correlates significantly with body mass index and steatosis.
Hourigan LF; Macdonald GA; Purdie D; Whitehall VH; Shorthouse C; Clouston A; Powell EE
Hepatology; 1999 Apr; 29(4):1215-9. PubMed ID: 10094967
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis in chronic hepatitis B: contributing factors and effect on fibrosis.
Elloumi H; Hefaiedh R; Gargouri D; Chedly-Debbiche A; Khayat O; Bel Hadj N; Kharrat J; Ghorbel A
Tunis Med; 2008 Nov; 86(11):1000-3. PubMed ID: 19213493
[TBL] [Abstract][Full Text] [Related]
15. Fibrosis progression in initially mild chronic hepatitis C.
Boccato S; Pistis R; Noventa F; Guido M; Benvegnù L; Alberti A
J Viral Hepat; 2006 May; 13(5):297-302. PubMed ID: 16637859
[TBL] [Abstract][Full Text] [Related]
16. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
[TBL] [Abstract][Full Text] [Related]
17. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
Stránský J; Ryzlová M; Striteský J; Horák J
Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
[TBL] [Abstract][Full Text] [Related]
18. Hepatic steatosis and fibrosis in chronic hepatitis C in Taiwan.
Hsieh MH; Lee LP; Hsieh MY; Tsai KB; Huang JF; Hou NJ; Chen SC; Lin ZY; Hsieh MY; Wang LY; Dai CY; Chuang WL; Yu ML
Jpn J Infect Dis; 2007 Nov; 60(6):377-81. PubMed ID: 18032828
[TBL] [Abstract][Full Text] [Related]
19. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
Halfon P; Pénaranda G; Carrat F; Bedossa P; Bourlière M; Ouzan D; Renou C; Tran A; Rosenthal E; Wartelle C; Delasalle P; Cacoub P
Aliment Pharmacol Ther; 2009 Jul; 30(1):61-70. PubMed ID: 19292832
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance is associated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C.
Cammà C; Bruno S; Di Marco V; Di Bona D; Rumi M; Vinci M; Rebucci C; Cividini A; Pizzolanti G; Minola E; Mondelli MU; Colombo M; Pinzello G; Craxì A
Hepatology; 2006 Jan; 43(1):64-71. PubMed ID: 16374856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
